BackAxogen Overview

Axogen Research & Development

Research & Development expenses for AXGN.

Quarterly R&D Expenses

$7.52M
23.41% YoY

As of Mar 31, 2026

Annual R&D Expenses (TTM)

$34.31M
29.59% YoY

Trailing 12 months ending Mar 31, 2026

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)